Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients.

Xu C, Yu L, Zhan P, Zhang Y.

Eur J Med Res. 2014 May 8;19:23. doi: 10.1186/2047-783X-19-23.

PMID:
24887477
[PubMed - in process]
Free PMC Article
2.

Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.

Park DS, Kim D, Hwang KE, Hwang YR, Park C, Seol CH, Cho KH, Kim BR, Park SH, Jeong ET, Kim HR.

Yonsei Med J. 2013 Mar 1;54(2):396-402. doi: 10.3349/ymj.2013.54.2.396.

PMID:
23364973
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions.

Park DS, Hwang KE, Shim H, Kim BR, Choi KH, Park SH, Park SD, Jeong ET, Kim HR.

Clin Exp Metastasis. 2012 Feb;29(2):83-9. doi: 10.1007/s10585-011-9431-7. Epub 2011 Nov 2.

PMID:
22045227
[PubMed - indexed for MEDLINE]
4.

Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.

Hsu IL, Su WC, Yan JJ, Chang JM, Lai WW.

Lung Cancer. 2009 Sep;65(3):371-6. doi: 10.1016/j.lungcan.2008.12.007. Epub 2009 Jan 21.

PMID:
19157636
[PubMed - indexed for MEDLINE]
5.

Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients.

Aoe K, Hiraki A, Yamazaki K, Nakamura Y, Murakami T, Maeda T, Nishimura M, Sugi K, Ueoka H.

Int J Oncol. 2006 Jul;29(1):65-72.

PMID:
16773186
[PubMed - indexed for MEDLINE]
6.

Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.

Xu CH, Zhan P, Yu LK, Zhang XW.

Tumour Biol. 2014 Feb;35(2):1599-603. doi: 10.1007/s13277-013-1220-2. Epub 2013 Sep 26.

PMID:
24072496
[PubMed - indexed for MEDLINE]
7.

Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.

Görgün D, Seçik F, Midilli K, Akkaya V, Yıldız P.

Respir Med. 2013 Aug;107(8):1260-5. doi: 10.1016/j.rmed.2013.04.011. Epub 2013 Jun 18.

PMID:
23791464
[PubMed - indexed for MEDLINE]
8.

Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.

Qian Q, Zhan P, Sun WK, Zhang Y, Song Y, Yu LK.

Neoplasma. 2012;59(4):433-9. doi: 10.4149/neo_2012_056.

PMID:
22489699
[PubMed - indexed for MEDLINE]
9.

An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer.

Chen YM, Yang WK, Whang-Peng J, Tsai CM, Perng RP.

Lung Cancer. 2001 Jan;31(1):25-30.

PMID:
11162863
[PubMed - indexed for MEDLINE]
10.

Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.

Hung TL, Chen FF, Liu JM, Lai WW, Hsiao AL, Huang WT, Chen HH, Su WC.

Clin Cancer Res. 2003 Jul;9(7):2605-12.

PMID:
12855637
[PubMed - indexed for MEDLINE]
Free Article
11.

Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma.

Qian Q, Sun WK, Zhan P, Zhang Y, Song Y, Yu LK.

Int J Biol Markers. 2012 Jul 19;27(2):e118-24. doi: 10.5301/JBM.2012.9197.

PMID:
22505233
[PubMed - indexed for MEDLINE]
12.

Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy.

Hoheisel G, Izbicki G, Roth M, Chan CH, Reichenberger F, Schauer J, Perruchoud AP.

Respiration. 1998;65(3):183-6.

PMID:
9670298
[PubMed - indexed for MEDLINE]
13.
14.

Diagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions.

Bai CQ, Yao YW, Liu CH, Zhang H, Xu XB, Zeng JL, Liang WJ, Yang W, Song Y.

J Thorac Dis. 2014 May;6(5):483-90. doi: 10.3978/j.issn.2072-1439.2014.02.14.

PMID:
24822107
[PubMed]
Free PMC Article
15.

Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.

Shin YM, Yun J, Lee OJ, Han HS, Lim SN, An JY, Lee KH, Lee KM, Choe KH.

Cancer Res Treat. 2014 Apr;46(2):178-85. doi: 10.4143/crt.2014.46.2.178. Epub 2014 Apr 22.

PMID:
24851110
[PubMed]
Free PMC Article
16.

[Determination and significance of interleukin-16 in tuberculous and malignant pleural effusion].

Huang ZX, Shi HZ, Kang LF, Qin XJ, Mo WN, Chen YQ.

Zhonghua Nei Ke Za Zhi. 2006 Mar;45(3):199-201. Chinese.

PMID:
16624150
[PubMed - indexed for MEDLINE]
17.

IL-33 levels differentiate tuberculous pleurisy from malignant pleural effusions.

Xuan WX, Zhang JC, Zhou Q, Yang WB, Ma LJ.

Oncol Lett. 2014 Jul;8(1):449-453. Epub 2014 May 2.

PMID:
24959294
[PubMed]
Free PMC Article
18.

Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.

Xu CH, Hao KK, Yu LK, Zhang XW.

Asia Pac J Clin Oncol. 2014 Apr 11. doi: 10.1111/ajco.12195. [Epub ahead of print]

PMID:
24720371
[PubMed - as supplied by publisher]
19.

The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.

Wang Y, Chen Z, Chen J, Pan J, Zhang W, Pan Q, Ding H, Lin X, Wen X, Li Y, Meng QH.

Clin Chim Acta. 2013 Jun 5;421:230-5. doi: 10.1016/j.cca.2013.03.013. Epub 2013 Mar 21.

PMID:
23523589
[PubMed - indexed for MEDLINE]
20.

Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer.

Zhang H, Liu HB, Yuan DM, Wang ZF, Wang YF, Song Y.

BMC Cancer. 2014 Apr 23;14:280. doi: 10.1186/1471-2407-14-280.

PMID:
24758329
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk